Samphire Neuroscience

Seed
samphireneuro.com Biotech & Healthcare
Total Funding $2.3M
Latest Round Undisclosed Seed
Last Announced Jun 2, 2025
Investors 1 Backer
Decision Makers 3 Verified

About Samphire Neuroscience

For decades we have treated hormones, when we should have been treating the brain. Samphire builds advanced brain based technologies to tackle pain and mood symptoms caused by hormonal change.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website samphireneuro.com
Domain Registered Date Nov 23, 2021

Social & Network Presence

X / Twitter Profile @SamphireNeuro (42 followers) Created on Nov 2021
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Seed announced

    fundraisingfox.com

  2. Capital Raise

    Raised $2,300,000 · Pre-Seed

    fundraisingfox.com

  3. Milestone

    X account created (@SamphireNeuro)

    42 followers

  4. Milestone

    Website domain registered

    samphireneuro.com

Investors & Backers

1
HAX

Funding History

3 Rounds
Seed · Jun 2, 2025
Pre-Seed · Feb 21, 2024
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

2

Alex Cook

COO (Founder)

Work email & phone locked Unlock →

Emilė Radytė

CEO (Founder)

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts